All good points but I’m personally looking forward to hearing from our new CSO. Would love to hear him talk about his experiences with the FDA and his thoughts on our BLA roadmaps and timelines.

I'm expecting big things from Dr. Rahman, and I think this webcast is a great opportunity to introduce him to the analysts and institutional investors who are listening. He adds unequivocal credibility to our operations.